Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Covid-19 and Thrombotic Thrombocytopenic Purpura: A Case Report Publisher



Darnahal M1 ; Tehrani HA1 ; Vaezi M2 ; Haghighi S1
Authors

Source: International Journal of Hematology-Oncology and Stem Cell Research Published:2021


Abstract

Endothelial injury by toxins, drugs, immune complexes leads to activation of coagulation cascade and thrombosis, which result in platelet consumption and red blood cell injury. These thrombotic microangiopathies can potentially injure numerous organs and result in organ dysfunction. In this case, we present the fourth reported patient with thrombotic thrombocytopenic purpura associated with COVID-19. © 2021, Tehran University of Medical Sciences. All rights reserved.
Other Related Docs
7. Cancer-Associated Thrombotic Microangiopathy; a Review Article, Journal of Renal Injury Prevention (2024)
15. Thrombotic Thrombocytopenia After Sinopharm Bbibp-Corv Covid-19 Vaccination, Research and Practice in Thrombosis and Haemostasis (2022)
19. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)
20. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)